871792-61-9 Usage
Uses
Used in Pharmaceutical Research and Development:
4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine(SALTDATA: 2HCl) is used as a key intermediate in the synthesis of various pharmaceutical compounds for the treatment of central nervous system disorders. Its unique structure allows for the development of drugs with novel mechanisms of action, offering new therapeutic options for patients.
Used in Drug Design and Medicinal Chemistry:
In the field of drug design, 4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine(SALTDATA: 2HCl) serves as a valuable building block for the creation of new molecules with potential therapeutic properties. Its heterocyclic nature and fused rings provide a versatile scaffold for medicinal chemists to modify and optimize the pharmacological profile of drug candidates.
Used in Neuropharmacology:
4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine(SALTDATA: 2HCl) is utilized in neuropharmacological research to investigate its potential as a modulator of neurotransmission and neuronal function. Its interaction with various receptors and enzymes in the central nervous system can provide insights into the development of new treatments for neurological and psychiatric disorders.
Used in Chemical Synthesis:
As a stable and water-soluble dihydrochloride salt, 4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine(SALTDATA: 2HCl) is employed in various chemical synthesis processes. Its reactivity and functional groups make it a suitable candidate for the preparation of a range of organic compounds, including pharmaceuticals, agrochemicals, and other specialty chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 871792-61-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,1,7,9 and 2 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 871792-61:
(8*8)+(7*7)+(6*1)+(5*7)+(4*9)+(3*2)+(2*6)+(1*1)=209
209 % 10 = 9
So 871792-61-9 is a valid CAS Registry Number.
871792-61-9Relevant articles and documents
A Continuous Flow Strategy for the Facile Synthesis and Elaboration of Semi-Saturated Heterobicyclic Fragments
Luise, Nicola,Wyatt, Eleanor W.,Tarver, Gary J.,Wyatt, Paul G.
, p. 1341 - 1349 (2019/01/14)
An efficient hydrogenation protocol under continuous flow conditions was developed for the synthesis of underrepresented semi-saturated bicyclic fragments containing highly sp3-rich skeletons for fragment-based drug discovery (FBDD) programs. Excellent yields were generally achieved by using Pd/C (10 % w/w) and RaNi at 25–150 °C under 4–100 bar of hydrogen pressure. The generated fragments, with appropriate physicochemical properties, present diverse hydrogen-bonding pharmacophores and useful vectors for their synthetic elaboration in the optimization stage. Successive, simple functionalizations in continuous flow were accomplished to demonstrate the opportunity to develop multi-step continuous flow synthesis of valuable starting points for FBDD campaigns. A conclusive quality control (QC) was essential to discard those structures which do not fit the typical fragment library parameters.
